StockData
Bluejay Diagnostics, Inc. logo

Bluejay Diagnostics, Inc. (BJDX) stock

BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$1.83−0.32 (-15.08%)

Close on Nov 18, 2026Market cap $8.18MP/E –Yield –

Bluejay Diagnostics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Bluejay Diagnostics's operating income for the twelve months ending Jun 30, 2026 was -$7.37M. For fiscal 2025 it was -$6.95M. The highest annual figure on record is -$1.20M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$6.95M–
FY2024Dec 31, 2024-$7.17M–
FY2023Dec 31, 2023-$10.31M–
FY2022Dec 31, 2022-$9.32M–
FY2021Dec 31, 2021-$3.23M–
FY2020Dec 31, 2020-$1.20M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.35M–
Q1 FY2026Mar 31, 2026-$1.94M–
Q4 FY2025Dec 31, 2025-$1.46M–
Q3 FY2025Sep 30, 2025-$1.62M–
Q2 FY2025Jun 30, 2025-$1.99M–
Q1 FY2025Mar 31, 2025-$1.89M–
Q4 FY2024Dec 31, 2024-$1.48M–
Q3 FY2024Sep 30, 2024-$1.36M–
Q2 FY2024Jun 30, 2024-$1.90M–
Q1 FY2024Mar 31, 2024-$2.43M–
Q4 FY2023Dec 31, 2023-$2.39M–
Q3 FY2023Sep 30, 2023-$2.34M–
Q2 FY2023Jun 30, 2023-$2.90M–
Q1 FY2023Mar 31, 2023-$2.68M–
Q4 FY2022Dec 31, 2022-$2.45M–
Q3 FY2022Sep 30, 2022-$2.81M–
Q2 FY2022Jun 30, 2022-$1.99M–
Q1 FY2022Mar 31, 2022-$2.07M–
Q4 FY2021Dec 31, 2021-$1.37M–
Q3 FY2021Sep 30, 2021-$957.99K–
Q2 FY2021Jun 30, 2021-$666.07K–
Q1 FY2021Mar 31, 2021-$233.20K–
Q4 FY2020Dec 31, 2020-$581.78K–
Q3 FY2020Sep 30, 2020-$148.17K–

More Bluejay Diagnostics figures

See a number that looks wrong?